购物车
  • 全部删除
  • TargetMol
    您的购物车当前为空

SB-431542

Rating icon 很棒
产品编号 T1726Cas号 301836-41-9
别名 SB 431542, 4-[4-(1,3-苯并二唑-5-基)-5-(2-吡啶基)-1H-咪唑-2-基]-苯酰胺水合物

SB-431542 是一种 ALK5/TGF-β type I Receptor 的抑制剂 (IC50=94 nM),具有选择性。SB 431542 对 ALK4 和 ALK7 也有抑制活性,但对其他蛋白没有抑制作用。SB 431542 可以用于干细胞的诱导分化。

SB-431542
TargetMol

为众多的药物研发团队赋能,

让新药发现更简单!

SB-431542

Rating icon 很棒
纯度: 100%
产品编号 T1726 别名 SB 431542, 4-[4-(1,3-苯并二唑-5-基)-5-(2-吡啶基)-1H-咪唑-2-基]-苯酰胺水合物Cas号 301836-41-9

SB-431542 是一种 ALK5/TGF-β type I Receptor 的抑制剂 (IC50=94 nM),具有选择性。SB 431542 对 ALK4 和 ALK7 也有抑制活性,但对其他蛋白没有抑制作用。SB 431542 可以用于干细胞的诱导分化。

规格价格库存数量
5 mg¥ 412现货
10 mg¥ 667现货
50 mg¥ 2,530现货
100 mg¥ 3,570现货
1 mL x 10 mM (in DMSO)¥ 519现货
大包装 & 定制
加入购物车
实验操作小课堂
查看更多

"SB-431542"的相关化合物库

选择批次:
纯度:99.87%
联系我们获取更多批次信息
TargetMol 的所有产品仅用作科学研究或药证申报,不能被用于人体,我们不向个人提供产品和服务。请您遵守承诺用途,不得违反法律法规规定用于任何其他用途。

产品介绍

生物活性
产品描述
SB-431542 is an inhibitor of ALK5/TGF-β type I Receptor (IC50=94 nM) and is selective. SB 431542 also has inhibitory activity against ALK4 and ALK7 but not other proteins. SB 431542 can be used for induced differentiation of stem cells.
靶点活性
ALK5:94 nM, ALK4:140 nM
体外活性
方法:人肾细胞 293T、人类结肠癌来源的非致瘤性细胞 FET 和人肺腺癌细胞 A549 用 SB-431542 (2-10 μM) 和 TGF-β1 (12.5 ng/mL) 处理 1 h,使用 Western Blot 方法检测靶点蛋白表达水平。
结果:TGF-β1 诱导了 Smad2/3 和 Smad4 之间的复合物形成。SB-431542 以剂量依赖的方式,通过阻断 TGF-β 诱导的磷酸化和Smad2/3的激活,阻断复合物形成。[1]
方法:人胶质母细胞瘤细胞 D54MG 用 SB-431542 (1-10 μM) 处理 24 h,使用 Transwell 方法检测细胞迁移情况。
结果: SB-431542抑制 TGF-βRI 信号传导以浓度依赖的方式阻断 D54MG 细胞的细胞迁移。[2]
方法:人多能干细胞 hESCs 用含 SB-431542 (10 nM) 和 Noggin (500 ng/mL) 的 KSR 培养基培养 11 天,使用 Immunofluorescence 方法检测细胞分化情况。
结果:神经诱导通过 PAX6 的表达来监测,PAX6 是神经直肠真皮分化的早期标志物。与单独使用 Noggin 或 SB-431542 时不到 10% 的 PAX6+ 细胞相比,用 Noggin 和 SB-431542 联合处理显著提高了神经诱导的效率,使其超过总细胞的 80%。[3]
体内活性
方法:为检测体内抗肿瘤活性,将 SB-431542 (10 mg/kg in 20% DMSO/80% corn oil) 腹腔注射给携带小鼠乳腺癌肿瘤 4T1 的 Balb/c 小鼠,每周三次,持续四周。
结果:SB-431542 可显著抑制 4T1 乳腺肿瘤的肺转移。[4]
方法:为研究肌腱损伤的治疗方法,将 SB-431542 (10 mg/kg) 腹腔注射给大面积肩袖撕裂的 C57B/6J 小鼠模型,每天一次,持续二或六周。
结果:SB-431542 抑制 TGF-β1 信号传导可减少纤维化、脂肪浸润和肌肉重量减轻。SB-431542 治疗通过促进纤维/脂肪生成祖细胞 (FAP) 的凋亡,减少了损伤肌肉中 FAP 的数量,FAP 是肩袖肌纤维化和脂肪浸润的重要细胞来源。[5]
激酶实验
Kinase assays were performed with 65 nM GSTALK5 and 184 nM GST-Smad3 in 50 mM HEPES, 5 mM MgCl2, 1 mM CaCl2, 1 mM dithiothreitol, and 3 M ATP. Reactions were incubated with 0.5 μCi of [33P]γATP for 3 h at 30°C. Phosphorylated protein was captured on P-81 paper, washed with 0.5% phosphoric acid, and counted by liquid scintillation. Alternatively, Smad3 or Smad1 protein was also coated onto FlashPlate Sterile Basic Microplates. Kinase assays were then performed in FlashPlates with same assay conditions using either the kinase domain of ALK5 with Smad3 as a substrate or the kinase domain of ALK6 (BMP receptor) with Smad1 as substrate. Plates were washed three times with phosphate buffer and counted by TopCount [2].
细胞实验
A498 cells were seeded at 5,000 to 10,000 cells/well in 96-well plates. The cells were serum-deprived for 24 h and then treated with compounds for 48 h to assess the cellular toxicity. Cell viability is determined by incubating cells for 4 h with XTT labeling and electron coupling reagent. Live cells with active mitochondria produce an orange-colored product, formazan, which is detected using a plate reader at between A450 nm and A500 nm with a reference wavelength greater than 600 nm. The absorbance values correlate with the number of viable cells [2].
动物实验
BALB/c mice received intraperitoneal (i.p.) injections of colon-26 tumor cells. Three days after tumor cell inoculation, SB-431542 (1 μM solution, 100 μl/animal) or vehicle alone was directly injected into the peritoneal cavity. CTL activities were measured by a standard 4 h 51Cr release assay after culturing spleen cells with γ-irradiated tumor cells for five days in the absence of added growth factors. In vitro experiments, cell lysate of HLA-A*2402 positive gastric cancer cell line, OCUM-8, was incubated with human DC cultures for 4 h. After washing extensively, PBMCs obtained from the same volunteer as DCs were incubated for 7 days and measured CTL activity by 51Cr release assay. NK activity was tested using 51Cr release assay against K562 [4].
别名SB 431542, 4-[4-(1,3-苯并二唑-5-基)-5-(2-吡啶基)-1H-咪唑-2-基]-苯酰胺水合物
化学信息
分子量384.39
分子式C22H16N4O3
CAS No.301836-41-9
SmilesNC(=O)c1ccc(cc1)-c1nc(c([nH]1)-c1ccccn1)-c1ccc2OCOc2c1
密度1.373 g/cm3
储存&溶解度
存储Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice.
溶解度信息
DMSO: 16.67 mg/mL (43.36 mM)
10% DMSO+90% Saline: 0.1 mg/mL (0.26 mM), Please add co-solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately.
Ethanol: 3.8 mg/mL (10 mM)

计算器

  • 摩尔浓度 计算器
  • 稀释 计算器
  • 配液 计算器
  • 分子量 计算器

体内实验配液计算器

请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法:
TargetMol | Animal experiments比如您的给药剂量是 10 mg/kg ,每只动物体重 20 g ,给药体积 100 μLTargetMol | Animal experiments 一共给药动物 10 只 ,您使用的配方为 5% TargetMol | reagent DMSO+ 30%PEG300+ 5%Tween 80 + 60% ddH2O. 那么您的工作液浓度为 2 mg/mL
母液配置方法: 2 mg 药物溶于 50 μLDMSOTargetMol | reagent ( 母液浓度为 40 mg/mL ), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。
体内配方的制备方法:50μLDMSOTargetMol | reagent 母液,添加 300 μLPEG300TargetMol | reagent 混匀澄清,再加 50μLTween 80, 混匀澄清,再加 600μLddH2OTargetMol | reagent 混匀澄清

以上为“体内实验配液计算器”的使用方法举例,并不是具体某个化合物的推荐配制方式,请根据您的实验动物和给药方式选择适当的溶解方案。

1 请输入动物实验的基本信息
mg/kg
g
μL
2 请输入动物体内配方组成,不同的产品配方组成不同,如有配方需求,可先联系我们提供正确的体内配方。
% DMSO
%
%Tween 80
%ddH2O

剂量转换

对于不同动物的给药剂量换算,您也可以参考 更多

关键词

评论列表

4个月前
5.0
Rating icon 很棒

评论内容

Related Tags: buy SB-431542 | purchase SB-431542 | SB-431542 cost | order SB-431542 | SB-431542 chemical structure | SB-431542 in vivo | SB-431542 in vitro | SB-431542 formula | SB-431542 molecular weight